These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12851527)

  • 1. A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Felmeden DC; Blann AD; Spencer CG; Beevers DG; Lip GY
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):425-31. PubMed ID: 12851527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]).
    Felmeden DC; Spencer CG; Chung NA; Belgore FM; Blann AD; Beevers DG; Lip GY
    Am J Cardiol; 2003 Aug; 92(4):400-5. PubMed ID: 12914869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Spencer CG; Gurney D; Blann AD; Beevers DG; Lip GY;
    Hypertension; 2002 Jul; 40(1):61-6. PubMed ID: 12105139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical activity in relation to indices of endothelial function and angiogenesis factors in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Felmeden DC; Spencer CG; Blann AD; Beevers DG; Lip GY
    J Intern Med; 2003 Jan; 253(1):81-91. PubMed ID: 12588540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Felmeden DC; Blann AD; Lip GY
    Am J Hypertens; 2007 Jun; 20(6):699-704. PubMed ID: 17531931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
    Freestone B; Chong AY; Nuttall S; Lip GY
    Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
    J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Felmeden DC; Blann AD; Lip GY
    J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial function in patients with newly diagnosed type 2 diabetes receiving early intensive insulin therapy.
    Tian J; Wang J; Li Y; Villarreal D; Carhart R; Dong Y; Wen Y; Liu K
    Am J Hypertens; 2012 Dec; 25(12):1242-8. PubMed ID: 22895449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
    Lee KW; Blann AD; Lip GY
    Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet and haemorheological markers in 'high risk' hypertensives are improved by tighter blood pressure control and cardiovascular risk management: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Spencer CG; Gurney D; Felmeden DC; Blann AD; Beevers DG; Lip GY
    J Intern Med; 2004 Jan; 255(1):59-67. PubMed ID: 14687239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of peripheral flow reserve impairs endothelial function in conduit arteries of patients with essential hypertension.
    Lauer T; Heiss C; Preik M; Balzer J; Hafner D; Strauer BE; Kelm M
    J Hypertens; 2005 Mar; 23(3):563-9. PubMed ID: 15716698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of combination therapy with amlodipine and atorvastatin on plasma adiponectin levels in hypertensive patients with coronary artery disease: combination therapy and adiponectin.
    Li M; Xu A; Lam KS; Cheung BM; Tse HF
    Postgrad Med; 2011 Nov; 123(6):66-71. PubMed ID: 22104455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism.
    Nishizaka MK; Zaman MA; Green SA; Renfroe KY; Calhoun DA
    Circulation; 2004 Jun; 109(23):2857-61. PubMed ID: 15173035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide.
    Chong AY; Blann AD; Patel J; Freestone B; Hughes E; Lip GY
    Circulation; 2004 Sep; 110(13):1794-8. PubMed ID: 15364797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management.
    Felmeden DC; Spencer CG; Belgore FM; Blann AD; Beevers DG; Lip GY
    Am J Hypertens; 2003 Jan; 16(1):11-20. PubMed ID: 12517677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy.
    Lip GY; Blann AD; Jones AF; Lip PL; Beevers DG
    Am J Cardiol; 1997 Dec; 80(12):1566-71. PubMed ID: 9416937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand factor and soluble E-selectin in hypertension: influence of treatment and value in predicting the progression of atherosclerosis.
    Blann AD; Waite MA
    Coron Artery Dis; 1996 Feb; 7(2):143-7. PubMed ID: 8813446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study.
    Juonala M; Viikari JS; Laitinen T; Marniemi J; Helenius H; Rönnemaa T; Raitakari OT
    Circulation; 2004 Nov; 110(18):2918-23. PubMed ID: 15505080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.